Activated PI3K delta syndrome (APDS)
Activated PI3K delta syndrome (APDS) is a rare primary immunodeficiency (PI) that is often misdiagnosed as CVID or another antibody deficiency.
Activated PI3K delta syndrome (APDS) is a rare primary immunodeficiency (PI) that is often misdiagnosed as CVID or another antibody deficiency.
See if you qualify to participate in clinical trials evaluating new treatments and/or diagnostics for APDS.
Genetic testing is the only way to definitively diagnose APDS. Since PIs are inherited, family members of a confirmed patient should be genetically tested. While family members may not have the same symptoms or any symptoms, they may still carry the genetic variant and pass it on to their children.
Joenja
Leniolisib.
Approved to treat: Activated PI3K delta syndrome (APDS).
Ages: 12+
Report side effects/adverse events at safetyUS@pharming.com or +1-800-930-5221.
The Assistance Fund is an independent 501(c)(3) organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses.
This informational website for those affected by activated P13K delta syndrome (APDS) was developed by Pharming Healthcare, Inc. and intended for residents of the United States.
This page contains general medical and/or legal information that cannot be applied safely to any individual case. Medical and/or legal knowledge and practice can change rapidly. Therefore, this page should not be used as a substitute for professional medical and/or legal advice. Additionally, links to other resources and websites are shared for informational purposes only and should not be considered an endorsement by the Immune Deficiency Foundation.
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.